I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Sepsis is among the top ten causes of death.\[[@ref1][@ref2][@ref3]\] It is defined as a systemic inflammatory response syndrome of infectious origin. Progression results in severe sepsis, with the failure of one or more organ systems. Further progression leads to septic shock.\[[@ref4]\] Death in septic patients has been suggested to be due to multiple organ failures (MOF).\[[@ref5][@ref6]\] The mortality of septic shock may be as high as 50%.\[[@ref7]\] While treating the underlying cause of sepsis is important, symptomatic organ support is vital. This includes fluid resuscitation and vasoactive drugs to prevent MOF.\[[@ref8]\] The decision to give more fluid or to initiate vasoactive agents remains challenging, with inadequate or excessive treatment associated with suboptimal outcomes. For example, a greater positive fluid balance has been associated with increased mortality, while the sequelae of hypovolemia are well known.\[[@ref9][@ref10]\] Added to these treatment challenges, the markers of fluid resuscitation, such as central venous pressure and pulmonary artery occlusion pressure, are less reliable than previously thought.\[[@ref11]\] Other dynamic markers may require special monitors or echocardiography skills.\[[@ref12]\] A simple objective tool to guide the direction of fluid therapy is much needed.

The concept of a fluid challenge is used to determine if a single bolus of fluid administered will increase cardiac preload and cardiac output significantly.\[[@ref13]\] Recent data suggest that only half of patients given a fluid challenge increase their oxygen delivery and only about half of these, increase their oxygen consumption thereby benefiting from fluid.\[[@ref14]\] Observational data show that even the use of the fluid challenge may not always have an impact on the prescription of further fluid when indicated by the presence of hypotension, oliguria, poor peripheral perfusion, elevated lactate, or even markers such as stroke volume (SV) variation and cardiac output.\[[@ref15]\]

Recently, one of the natriuretic peptides, B-type natriuretic peptide (BNP), was found to be elevated in septic shock.\[[@ref16]\] High levels of BNP and measures of left ventricular end-diastolic volume (LVEDV) and pressure were predictors of mortality.\[[@ref17][@ref18]\] BNP increases within an hour of physiological stimulation, such as caused by volume expansion and pressure overload of the cardiac ventricles. It is synthesized as a preprohormone and is ultimately processed to yield biologically active BNP and a fragment called NT-proBNP.\[[@ref19]\]

The aim of this pilot study was to examine the effect of a fluid challenge on BNP and the hemodynamic state focusing on the basic left ventricular (LV) characteristics. We hypothesized that a significant increase in BNP from any baseline value, soon after the fluid challenge, would indicate that the left ventricle was overstretched thereby providing additional data that may inform further fluid therapy.

S[UBJECTS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
================================================

The study was approved by the local Human Research Ethics Committee. This observational study was conducted in an intensivist-led university-affiliated mixed medical-surgical Intensive Care Unit (ICU).

Patient population {#sec2-1}
------------------

Patients admitted to the ICU over a 6-month period were considered for enrolment. Eligible patients were those admitted to the adult ICU and were diagnosed as being in septic shock or with severe sepsis within 48 h of admission to the ICU. Patients were enrolled in the first 12 h of meeting eligibility criteria. The patients had to have had a fluid challenge requested by the treating physician who deemed the hemodynamic parameters abnormal, with signs of hypoperfusion, as described by the International Guidelines for the Management of Severe Sepsis and Septic Shock.\[[@ref20]\] Patients with known cardiac disease or active hemorrhage were excluded from the study. The diagnosis of severe sepsis and septic shock was made using the consensus definitions of the American College of Chest Physicians/Society of Critical Care Medicine.\[[@ref4]\]

Baseline data collection {#sec2-2}
------------------------

Acute Physiology and Chronic Health Evaluation (APACHE) II scores were calculated and recorded for the first 24 h following admission to the ICU.\[[@ref21]\] Demographic data, including age, weight, height and gender, were also collected.

Procedure at initiation of fluid challenge {#sec2-3}
------------------------------------------

The mean arterial pressure (MAP) (MAP1) and heart rate (HR) (HR1) were recorded at the initiation of the fluid challenge. Blood was collected into an ethylenediaminetetraacetic acid (EDTA) tube for the measurement of BNP at baseline (BNP1). A short focused transthoracic echocardiogram (TTE) was performed. A 500 ml fluid challenge was administered within 30 min.

Procedure at the end of fluid challenge {#sec2-4}
---------------------------------------

The MAP2 and HR2 were recorded at the end of the fluid challenge. A short focused TTE was repeated at the end of the fluid challenge. One hour after the completion of the fluid challenge, blood was collected into an EDTA tube for a second measurement of BNP (BNP2).

Focused transthoracic echocardiogram {#sec2-5}
------------------------------------

Echocardiograms were performed by two intensive care echocardiographers who routinely perform TTEs in the ICU. The same operator performed both echocardiograms on each patient. The left parasternal long axis and short axis views were used for speed and consistency. The left ventricular end-diastolic dimension (LVEDd) was measured before (LVEDd1) and after (LVEDd2) the fluid challenge. Teichholz\'s m-mode formula was used to calculate the LVEDV (LVEDV1 and LVEDV2), SV (SV1 and SV2), and ejection fraction (EF) (EF1 and EF2) as above.\[[@ref22]\] Impaired LV systolic function was defined as an EF measured at baseline (EF1) below 50%.\[[@ref22][@ref23][@ref24][@ref25]\]

B-type natriuretic peptide measurement {#sec2-6}
--------------------------------------

BNP was measured using the point of care Triage^®^ instrument (Alere, San Diego, California, USA) utilizing a double-labeled fluorescent immunoassay.

Statistical analysis {#sec2-7}
--------------------

### Sample size {#sec3-1}

Calculation of sample size requirements was based on the modeling of the percentage change in SV as a function of selected study variables. In regression analysis, at least five cases (preferably 15--20) per estimated parameter are required; thus with thirty cases, the estimation of at most six parameters is possible, and we must be aware of the possibility of overfitting the data (i.e., the results may not be generalizable).

The relationship between the change in SV and the selected study variables was assessed by multiple linear regressions. Continuous variables were summarized by the mean, standard deviation, median, and interquartile range. Wilcoxon rank-sum test and the *t*-test were used for comparison of nonparametric and normally distributed continuous variables, respectively. Correlations were determined using Pearson\'s correlation. Data analysis was carried out using SAS. The 5% significance level was used.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Patient characteristics {#sec2-8}
-----------------------

Thirty patients with severe sepsis or septic shock were included in the study. At the time of enrolment, patients had two or more organ systems with dysfunction, requiring positive pressure ventilation and cardiovascular support in the form of either fluid support alone or fluid and vasopressor/inotrope support. Patients were admitted from several disciplines: trauma (9), surgery (6), obstetrics and gynecology (5), medicine (4), vascular surgery (1), and other (5). There were 16 females and 14 males. Baseline demographics are shown in [Table 1](#T1){ref-type="table"}.

###### 

Baseline demographics of study participants

![](IJCCM-21-117-g001)

Hemodynamic characteristics {#sec2-9}
---------------------------

[Table 2](#T2){ref-type="table"} shows hemodynamic parameters, echocardiographic measurements, and laboratory markers recorded at baseline and subsequent to a fluid challenge. The physiological parameters representing preload, afterload, and contractility in [Table 2](#T2){ref-type="table"} are studied further in a multiple regression models. Thirteen (13) of the thirty (30) patients had impaired systolic function with an EF of \<50% at baseline before a fluid challenge.

###### 

Baseline and post fluid challenge data for physiological variables Means and medians are provided with standard deviations and interquartile ranges in parenthesis

![](IJCCM-21-117-g002)

Fluid responders {#sec2-10}
----------------

Using multiple linear regressions, we explored the relationship between the percentage change (%) in SV and the following selected independent study variables to confirm and identify a group of fluid responders: percentage change in MAP, percentage change in LVEDV/LVEDd, percentage change in EF, percentage change in HR, and APACHE II score. There were no strong correlations (*r* \> 0.75) between the independent variables used. The overall model was significant and explained 98% of the variation (*P* \< 0.0001). Given all other variables in the model, a 1% increase in SV was associated with a 0.12% increase in MAP, a 1.1% increase in LVEDV, a 1.2% increase in EF, and a 0.6 point decrease in APACHE II score. Note that LVEDd was the only independent variable used to calculate LVEDV, and therefore these two variables were not considered separately.

Preload characteristics {#sec2-11}
-----------------------

[Table 3](#T3){ref-type="table"} describes the relationship between the left ventricle and SV increase. LVEDV1 (before the fluid challenge) was significantly larger in the fluid nonresponders (%SV increase \<15%) vs. the responders (%SV increase ≥15%). The percentage increase in LVEDV postfluid challenge was significantly higher in the fluid responders. Since LVEDV was calculated from LVEDd, these two variables were highly correlated (Pearson\'s *r* = 0.93, *P* \< 0.0001 for LVEDd1 and LVEDV1).

###### 

Preload characterictics in fluid responders and non responders defined by a threshold value of 15%. Means and medians are provided with standard deviations and interquartile ranges in parenthesis

![](IJCCM-21-117-g003)

Left ventricular size and B-type natriuretic peptide {#sec2-12}
----------------------------------------------------

We then looked at the relationship between change in BNP and the directly measured dimension of the left ventricular at end diastole (LVEDd). We found a significant but moderate correlation (Pearson\'s *r* = 0.4, *P* \< 0.035) between percentage change in BNP and LVEDd before the fluid challenge (LVEDd1).

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

The aim of the study was to examine changes in the hemodynamic state and BNP after the implementation of a fluid challenge among critically ill patients with severe sepsis. Recent evidence suggests that a fluid restrictive strategy and active diuresis during the shock-free period may aid in the management of acute lung injury.\[[@ref26][@ref27]\] We selected a group of patients in whom a hemodynamic strategy might be useful. They were critically ill patients requiring pulmonary and cardiovascular support.

Sepsis induces reversible myocardial dysfunction that may manifest clinically with a reduced EF.\[[@ref28][@ref29]\] Septic cardiomyopathy occurs commonly and is often underappreciated as hemodynamic parameters may be within reference limits or elevated in the presence of a lowered systemic vascular resistance secondary to vasodilatation.\[[@ref30][@ref31]\] This is evident in our study as 43% of the group had impaired LV systolic function at baseline. In keeping with this, we also found that severity of illness (a higher APACHE II score) was an independent predictor of a smaller SV response to the fluid challenge.

Overall, we found significant changes in the hemodynamic state following the fluid challenge. The SV can be defined by cardiac function and venous return curves.\[[@ref32]\] According to our multivariate model, the increase in SV was independently predicted by the increase in LVEDV/LVEDd (preload), MAP (afterload), and contractility (EF). The LVEDV1 (before fluid challenge) was greater and the percentage increase in LVEDV was smaller for smaller SV increments (nonresponder). These patients had a larger LV volume with likely overstretching of the muscle fibers beyond optimal length, and hence a possible reduction in isometric tension and contraction. The question we hoped to answer was whether this state may be predicted by an increase in BNP.

The BNP gene contains a "TATTAT" sequence indicating a high turnover rate at an mRNA level and a high synthesis rate. Once a physiological stimulus occurs, expression occurs within an hour.\[[@ref33]\] The BNP measurement was repeated after an hour of completion of the fluid challenge to detect an increase in volume or pressure, while keeping the period as short as possible to exclude other factors that may cause BNP to change. The goal was to select a time at which the BNP change was most likely due to the fluid challenge. The test is point of care with results available within 15 min at the bedside making it practical in the ICU. BNP levels have been found to be elevated in patients with symptomatic heart failure and also in critically ill patients.\[[@ref18][@ref34]\]

In this pilot study of only thirty patients, we found that the percent increase in BNP 1 h after the fluid challenge was positively correlated with a larger baseline LV size at end diastole. The characteristic of a fluid nonresponder was a smaller percentage increase in preload, associated with a larger baseline value, and this was predicted to some extent by the increase in BNP. An increase in BNP would imply that there was an increase in LV end-diastolic volume and pressure.\[[@ref34]\] Even though high levels of BNP might be related to an alteration in BNP clearance during sepsis, acute ventricular stretching has been shown to result in further BNP release during these conditions.\[[@ref16]\] We repeated the BNP at 1 h postcompletion of the fluid challenge in an attempt to isolate this relationship between BNP and fluid challenge from any other prevailing conditions that may impact on the BNP concentration. Rather than using the absolute value of BNP at any point, as this may be influenced by numerous other factors, we used the change in BNP at 60 min after completing the fluid challenge.

Limitations {#sec2-13}
-----------

First, we used a point of care BNP assay. It is important to note that the average coefficient of variation (precision) of the BNP assay according to the manufacturer\'s package insert is 15.4% (Triage^®^ instrument, Alere, San Diego, California, USA). This large imprecision may introduce significant error. Second, our measurements for LVEDV were based on Teichholz\'s calculation, while more accurate measures exist. Third, we did not have a control group who did not receive a fluid challenge and therefore cannot completely exclude confounders for the change in BNP. Finally, it is a very small study.

C[ONCLUSIONS]{.smallcaps} {#sec1-5}
=========================

We have described the hemodynamic response to a fluid challenge in a group of critically ill patients with severe sepsis who are likely to benefit from a fluid strategy. We have found that the SV response is dependent on the responses of the LVEDV/LVEDd, the MAP, and EF. Of these, there exists a moderate but significant relationship between baseline LV size and % change in BNP regardless of its baseline value. The potential for using the change in BNP with the fluid challenge concept needs more rigorous evaluation.
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